Daewon Pharmaceutical's plan for the overseas advance of its non-steroidal anti-inflammatory drug (NSAID), Pelubi, has ground to a halt because of the prolonging Russian war in Ukraine.Daewon had conducted domestic clinical trials for Pelubi for the past two years to advance to Russia. The company r
T&R Biofab, a 3D bioprinting company, said Thursday that it has obtained a Japanese patent for heart disease treatment technology using induced pluripotent stem cells (iPSCs).The technology is used to manufacture a 3D micro cardiac spheroid, a three-dimensional heart structure of uniform 100 microme
Daewoong Pharmaceutical said Thursday that it has signed a contract development and manufacturing organization (CDMO) agreement with Yonsei University Wonju College of Medicine (YUWCM) to develop stem cell-based hearing loss therapies.With this contract, the two institutions will collaborate to esta
Sanofi Aventis Korea’s labor union criticized management for using excessive and unfair discipline against workers for years and pointed to the company’s Ethics & Business Integrity (E&BI) program as the main culprit.Unionized workers claimed that the E&BI department in Korea misinterpreted the glob
Antiviral drug developer ImmuneMed said Wednesday that its candidate substance for Covid-19 treatment, burfiralimab, will soon enter into phase 3 clinical trials after receiving approval from Indonesia’s National Agency of Drug and Food Control (BPOM).The company said the Indonesian approval marked
Huons said it would supply its local anesthetic product to McKesson, a U.S. drug distribution company, through its U.S. subsidiary Huons USA.Under the accord, Huons plans to export a “5mL vial of 1 percent lidocaine hydrochloride injection,” which received U.S. Food and Drug Administration’s Abbrevi
Chinese pharmaceutical companies, including Antengene, Everest Medicines, and BeiGene, established Korean offshoots recently. Unlike other Chinese companies that used to export drug ingredients to Korea, these companies aim to target the Korean market with innovative drugs for serious diseases like
Daewoong Pharmaceutical said it would develop a chronic skin disease treatment jointly with Scai Therapeutics, a drug delivery platform bio-venture, using transdermal absorption technology.The two companies will apply Scai Therapeutics' proprietary technology to develop a transdermal absorbable form
Novartis Korea said Tuesday that it obtained permission from the Ministry of Food and Drug Safety on June 9, to market Scemblix to treat adults with chronic myeloid leukemia who had received two or more tyrosine kinase inhibitors (TKI).Chronic myeloid leukemia is a malignant blood disease caused by
Helixmith has decided to postpone announcing the interim results of the U.S. phase 3 clinical trial for diabetic peripheral neuropathy (DPN) using its new gene therapy, Engensis (VM202), until next month, its top manager said.The company had planned to share the results of the Independent Data Monit
Celltrion said it would change its strategy for developing a Covid-19 treatment to respond to the rapidly changing pandemic situations after the emergence of the Omicron variant.For instance, the company will scrap its plan to develop an inhaled cocktail antibody treatment that adds CT-P63, a candid
Dae Hwa Pharm said it applied to the drug regulator for a change in the post-marketing surveillance (PMS) plan for Liporaxel (ingredient: paclitaxel), chemotherapy to extend the September deadline of the drug re-evaluation.The Ministry of Food and Drug Safety’s central pharmaceutical review committe
BL, a new drug developer, said Monday that it has obtained approval for administering patients with BLS-H01, a drug aimed at treating all Covid-19 variants.The Institutional Review Board (IRB) of Gachon University Gil Medical Center approved the phase 2 clinical trial of BLS-H01, a medication for Co
“In conducting this study, I met many insiders of the active pharmaceutical ingredient (API) industry, and most of them said, ‘We are like abandoned children,’ or ‘Everyone knows that the pharmaceutical industry can hardly move forward without a competitive API sector. Unfortunately, however, the go
The government has included vaccines and other biopharmaceutical technologies into its list of core strategy technology to produce raw materials, parts, and equipment, drawing keen attention from related industries.Last Thursday, the Ministry of Trade, Industry and Energy said it would add four biop
VT BIO said the company received approval to conduct clinical trials of its VT301 drug to treat Alzheimer's disease of antigen-specific self-regulated T cells by the U.S. Food and Drug Administration on Thursday.This U.S. clinical trial is the second one to treat Alzheimer's disease using regulated
Roche Diagnostics Korea said on Friday that their cobas EBV and cobas BKV tests for monitoring viruses and infections of organ transplant patients have received approval from the Ministry of Food and Drug Safety.The cobas EBV test indicates the need for potential treatment changes in patients under
Canaria Bio said that it has agreed to start a joint clinical trial with GSK in patients with platinum-sensitive recurrent ovarian cancer. The two companies aim to confirm the safety and efficacy of combination therapy using Canaria Bio's Oregovomab and GSK's Zejula (ingredient: niraparib).Canaria B
HLB Therapeutics will invest $30 million in Immunomic Therapeutics, HLB's U.S. affiliate developing the next-generation cell therapy anticancer vaccine.HLB Therapeutics said it signed a binding term sheet with Immunomic on Tuesday. Some outside investors also invested, acquiring bonds with warrants